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A switch element in the autophagy E2 Atg3
mediates allosteric regulation across
the lipidation cascade
Yumei Zheng 1,2,8, Yu Qiu 1,5,8, Christy R.R. Grace 1, Xu Liu 3,6,7, Daniel J. Klionsky 3 &
Brenda A. Schulman 1,2,4
Autophagy depends on the E2 enzyme, Atg3, functioning in a conserved E1-E2-E3 trienzyme
cascade that catalyzes lipidation of Atg8-family ubiquitin-like proteins (UBLs). Molecular
mechanisms underlying Atg8 lipidation remain poorly understood despite association of
Atg3, the E1 Atg7, and the composite E3 Atg12–Atg5-Atg16 with pathologies including
cancers, infections and neurodegeneration. Here, studying yeast enzymes, we report that an
Atg3 element we term E123IR (E1, E2, and E3-interacting region) is an allosteric switch. NMR,
biochemical, crystallographic and genetic data collectively indicate that in the absence of the
enzymatic cascade, the Atg3E123IR makes intramolecular interactions restraining Atg3′s
catalytic loop, while E1 and E3 enzymes directly remove this brace to conformationally
activate Atg3 and elicit Atg8 lipidation in vitro and in vivo. We propose that Atg3′s E123IR
protects the E2~UBL thioester bond from wayward reactivity toward errant nucleophiles,
while Atg8 lipidation cascade enzymes induce E2 active site remodeling through an unpre-
cedented mechanism to drive autophagy.
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Autophagy is a major catabolic pathway by whicheukaryotic cells degrade and recycle diverse cellularmaterials1. Sectors of the cytosol are ﬁrst sequestered
within a double-membrane-bound autophagosome, and then
degraded upon autophagosome fusion with the lysosome in
higher eukaryotes or vacuole in yeast2. Cargoes directed to
autophagosomes for degradation, include protein assemblies,
organelles, misfolded macromolecules, debris, and pathogenic
bacteria3–5. As such, autophagy plays important roles in cellular
metabolism in many physiological processes, while dysregula-
tion of autophagy is associated with metabolic, neurologic, and
oncologic disorders6–12.
Many facets of autophagy rely on the autophagy-speciﬁc ubi-
quitin-like protein (UBL) Atg8 in yeast (or six LC3- and
GABARAP-family UBLs in higher eukaryotes, here referred to
collectively as Atg8-family members) and the E1–E2–E3 enzymatic
cascade that links Atg8′s C-terminus to the primary amino head
group of phosphatidylethanolamine (PE) lipid molecules13–16.
Ultimately, lipidated Atg8-family members serve as bridges between
membranes and the cytosol, where their ubiquitin-like fold
domains recruit Atg8-interacting motif (AIM) or LC3-interaction
region (LIR) sequences in a staggering array of partner proteins
involved in various aspects of autophagy17–20. These, include
regulators and effectors of autophagosome biogenesis that pro-
mote membrane tethering and growth of the autophagosome, as
well as adaptor proteins that in turn recruit cargoes for degra-
dation21. Accordingly, Atg8 and its conjugation system enzymes
are essential for autophagy in yeasts, and autophagy is severely
impaired in their absence in mammalian cells22. Lipidated Atg8-
family members have also been implicated in protein recruitment
to membranes in processes that are unrelated to autophagy in
mammalian cells23. Therefore, given these important roles of
Atg8 and its conjugation system enzymes, it is important to
understand molecular mechanisms regulating Atg8 lipidation.
The central enzyme in the Atg8 lipidation cascade is the E2,
Atg313,24. Atg3 receives Atg8 from the E1 Atg7, to form a
covalent, reactive Atg3~Atg8 intermediate linked by a thioester
bond (referred to by ~) between the C-terminus of Atg8 and the
catalytic Cys of Atg3. Atg8 is then transferred from the Atg3
catalytic Cys to PE in a reaction catalyzed by a composite E3
enzyme25 containing another autophagy UBL, Atg12, conjugated
to Atg526. In vitro, the yeast Atg12–Atg5 conjugate is sufﬁcient to
serve as an E3 enzyme activating lipidation of Atg826. Atg16
binding to lipids substantially enhances E3 activity27 and is
required in vivo28 to localize Atg12–Atg5 to the pre-
autophagosomal structure that precedes autophagosome forma-
tion29,30, through many mechanisms31–33.
The prior structure of Atg3 from S. cerevisiae revealed a cat-
alytic core domain (Atg3cat) largely resembling E2s for canonical
UBLs such as Ub, NEDD8 and SUMO, including a long central
helix and two catalytic segments34 (Fig. 1a). One segment harbors
the catalytic Cys234, and the other displays Thr213, which also is
essential for the lipidation reaction and corresponds to the
canonical E2 catalytic Asn that plays a crucial structural
role13,35,36. In addition, Atg3 displays unique, functionally
important structures34,37,38: an N-terminal amphipathic
membrane-binding helix (N, residues 1–18); an intrinsically
disordered ﬂexible region (FR, residues 85–159); a handle region
consisting of a helix and a disordered region (HR, residues
237–282) that contains an Atg8-interacting motif that is dis-
pensable for the lipidation reaction but plays important roles
in vivo; and a ﬂexible extreme C-terminal extension (C, residues
299–310). While prior structural studies showed how Atg7
engages Atg3cat and the Atg3FR for Atg8 transfer to Atg339–43,
less is understood about subsequent roles of the autophagy E3. A
crystal structure showed how the human E3 enzyme recruits a
peptide-like region from Atg3′s FR, but this FR motif is not
conserved across Atg3 sequences from many organisms, includ-
ing yeasts44. Furthermore, the structure lacked Atg3′s
catalytic domain, for which prior studies of cysteine accessibility
in the yeast enzyme suggested that the autophagy E3
triggers a structural rearrangement that affects the orientation of
the catalytic Cys234 relative to Thr21335. The molecular under-
pinnings for E3-dependent conformational activation remains
elusive.
Here, we use a hybrid structural approach integrating infor-
mation from biochemistry, nuclear magnetic resonance (NMR),
crystallography, and yeast genetics to identify a molecular basis
for Atg3 allosteric activation. Overall, the data suggest that a
distinct peptide-like element acts like a brace mediating intra-
molecular interactions with the Atg3 catalytic domain to restrict
the conformation of the active site and prevent reactivity toward
errant nucleophiles, while the E3 elicits an unprecedented E2
activation mechanism by remotely binding to this brace to couple
other E3 interactions with allosteric activation of active site
mediating Atg8 lipidation.
Results
Autophagy E3 activates intrinsic reactivity of Atg3~Atg8.
E2–UB and E2–UBL intermediates are activated in distinct ways
by different classes of E3 enzymes45–47. Many E3s, for example
RING and related E3s for UB, NEDD8 and SUMO, and SIM-
containing SUMO E3s, allosterically promote noncovalent
interactions between the E2 and UB (or UBL) moieties within the
covalent intermediate. This is often monitored by an E3
increasing the susceptibility of an E2–UB or E2–UBL inter-
mediate to nucleophilic attack by a nonspeciﬁc amine nucleo-
phile48. In contrast, HECT and RBR E3s use a different
mechanism that depends on positioning the E2-bound UB for
transfer to the E3 catalytic Cys. Although the autophagy E3 lacks
homology to UB, NEDD8, and SUMO ligases, we asked whether
there are common mechanistic features by testing biochemical
activities of the relatively simplistic Atg8 pathway from S. cere-
visiae. Potential E3-mediated stimulation of intrinsic activity of
the Atg3~Atg8 intermediate was examined by adapting the pulse-
chase assay format used to study canonical UB enzymes (Fig. 1b).
Brieﬂy, a pulse-reaction catalyzed by Atg7 generated the
thioester-linked Atg3~Atg8 intermediate. After quenching this
reaction with apyrase, increasing concentrations of hydro-
xylamine were added (Fig. 1b). Discharge of the Atg3~Atg8
intermediate to this nonspeciﬁc amine nucleophile was mon-
itored by appearance of free Atg3 in sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE). Whereas the
Atg3~Atg8 intermediate was relatively stable on its own, addition
of Atg12–Atg5 stimulated discharge. This activation was main-
tained in the presence of Atg16, while Atg5-Atg16 alone was
insufﬁcient (Fig. 1b). Atg12–Atg5 is also known to be required for
E3 activation of the lipidation reaction26,27,35. Thus, within the
composite autophagy E3 is a module that activates the intrinsic
reactivity of the Atg3~Atg8 thioester-linkage.
As a ﬁrst step toward understanding the mechanism, we
performed mutagenesis based on the prior structure showing that
in the context of the human autophagy E3, Atg12 recruits a short
peptide-like region of Atg3′s FR44. Although the FR sequences from
human and yeast Atg3 are not conserved (Supplementary Fig. 1a),
the structures of human and yeast Atg12–Atg5 superimpose well,
including the Atg3FR-binding site (Fig. 1c)49,50. Mutations in the
corresponding surface of yeast Atg12–Atg5 not only impair Atg8
lipidation but also intrinsic activation of the Atg3~Atg8 inter-
mediate (Fig. 1d and Supplementary Fig. 1b, c). Thus, it seems
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probable that the FR from yeast Atg3 likewise contains an
E3-binding element.
Identiﬁcation of an E3-binding element in yeast Atg3. A
multi-tiered approach was used to identify the Atg3 element
determining E3 activation and binding. First, given that the
corresponding E3-binding element from human Atg3 is located
in the FR, a panel of Atg3 variants harboring individual or
multiple alanine mutations in the FR were monitored for E3-
dependent Atg3~Atg8 discharge (Fig. 2a and Supplementary
Fig. 2). Second, mutants hindering discharge were tested for
relevance to autophagy, by testing for effects on E3-dependent
Atg8 lipidation in vitro and in vivo (Fig. 2b, c). Finally, NMR was
used to deﬁne the Atg3FR region mediating E3-binding. After
resonances were assigned for a construct spanning the entire

















































































































Fig. 1 The Atg12–Atg5 module within the autophagy E3 activates intrinsic reactivity of the Atg3~Atg8 intermediate. a Structures of yeast Atg3 (left, PDB
2DYT), a ubiquitin E2 (middle, UBE2D1, PDB 4AP4), and their superimposition (right). Atg3 unique elements are indicated by colors shown in schematics
of Atg3 constructs used in this study (below). b Intrinsic reactivity of Atg3~Atg8 intermediate monitored by pulse-chase discharge to NH2OH in presence
of indicated E3 variant. c Close-up of structural superimposition of yeast Atg12–Atg5-Atg16 (PDB 3W1S) and corresponding human complex with ATG3FR
(PDB 4NAW). Residues from yeast Atg12 corresponding to the human ATG3FR-binding site are shown as red sticks. d Effects of mutations in minimal
yeast E3 (Atg12–Atg5) on stimulating Atg3~Atg8 discharge, monitored by quantiﬁcation of Atg3~Atg8 remaining after 2.5 min in pulse-chase assays using
the scheme as in (b), as a function of NH2OH concentration. (Error bar: STDEV, N= 3) Representative gel is shown in Supplemental Fig. 1b; all points are
shown in Source Data File
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version of the Atg12–Atg5 conjugate was added, and [15N, 1H]
TROSY spectra were examined for chemical shift perturbation
and/or line-broadening as an indicator of binding (Fig. 3a, c).
Although other residues in Atg3′s FR contribute to activity
(Fig. 2a), the major region implicated by all assays spans from
Ile129-Lys142 (Fig. 2a–c and Fig. 3a, c). For reasons described
below, we termed this region Atg3E123IR.
Atg3′s E3-binding element also binds E1 and E2. Prior studies
showed that the region corresponding to Atg3E123IR mediates
Atg3 recruitment to the autophagy E1, Atg742,51. In this upstream
step of the conjugation cascade, Atg3E123IR binding to Atg7′s N-
terminal domain (Atg7NTD) anchors the complex, thereby
increasing the local concentration for distal, transient interactions
between Atg7′s and Atg3′s catalytic domains for Atg8 transfer
between them43 (Fig. 4a). To further conﬁrm that as in the
human autophagy pathway52,53, E1 and E3 binding to Atg3 is
mutually exclusive for yeast enzymes, we examined the ability of
the isolated NTD from Atg7 to compete with Atg12–Atg5-
dependent activation of Atg3~Atg8. The wild-type Atg7NTD
inhibits the E3-dependent reaction, whereas a version harboring a
mutation (P283D) previously shown to impair Atg3 binding
(Fig. 4a)42 does not show this inhibitory effect, consistent with
mutually exclusive binding (Fig. 4b).
Intriguingly, this same E1- and E3-binding Atg3E123IR element
was also found to contact the Atg3cat domain in the prior crystal
structure of full-length Atg3 alone, although the interactions were
previously attributable to crystal packing and not tested further
(Fig. 1a)34. To address the potential for bona ﬁde interaction in
solution, we wished to perform NMR. This ﬁrst required
generation of suitable fragments from Atg3, because in prior
studies of the full-length protein, it was not possible to detect
resonances from the catalytic domain due to dramatically
different dynamic properties from the FR region34. Thus, the
isolated Atg3cat domain was prepared (construct listed in Fig. 1a),
and resonances observed in [15N–1H] TROSY spectra were
assigned (Fig. 4c). Intriguingly, resonances corresponding to
the active site loop (residues 232–236) were not assignable in the
spectrum, potentially due to motions on the millisecond or
intermediate exchange time scales.
[15N–1H] TROSY spectra obtained upon adding a synthetic
peptide corresponding to the Atg3FR element to 15N-labeled Atg3cat
(Fig. 4c), or upon adding an unlabeled version of Atg3ΔFR to 15N-
labeled Atg3FR (Fig. 4d), showed substantial chemical shift
perturbations. In both titrations, the perturbed resonances
correspond to the Atg3FR and Atg3cat domain residues observed
to interact in the crystal structure (Fig. 4f). Consistent with the
interactions, Introduction of mutations to hydrophobic residues
I132, L135, and I136 signiﬁcantly diminished the chemical shift
perturbations within E123IR (Supplementary Fig. 3a), and further
lower the E123IR-Atg3ΔFR binding afﬁnity (Supplementary Fig. 3b).
Thus, the NMR data conﬁrmed the Atg3E123IR element as a bona
ﬁde Atg3cat-binding element in solution. The term Atg3E123IR
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Fig. 2 E123IR plays essential role in E3-dependent Atg8 ligation activity. a Effects of indicated Ala mutants in Atg3′s FR on E3 (Atg12–Atg5-Atg16)
activation of Atg3~Atg8 intermediate, quantiﬁed as percent Atg3~Atg8 remaining in pulse-chase discharge to NH2OH over 2.5 min. Locations of most
defective and moderately defective mutants are indicated on schematics, and those corresponding to Atg3E123IR are shown in red. b Effects of indicated Ala
mutants in Atg3′s FR on Atg8 lipidation in vitro, in reactions with Atg7, Atg12–Atg5-Atg16, and liposomes generated from E. coli polar lipids as source of PE,
and detected by migration of Atg8 in Coommassie-stained SDS-PAGE gel. c Effects of indicated Ala mutants in Atg3′s FR on Atg8 lipidation in vivo, as
detected by western blot for Atg8 after 2 h starvation of XLY161 atg3Δpep4Δ strain of S. cerevisiae expressing either WT or mutant HA-tagged Atg3. Pgk1 is
loading control for Atg8, Dpm1 is loading control for Atg3
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Compared to the interaction with Atg12–Atg5 (Fig. 3b), we
observed lower binding afﬁnity between E123IR and Atg3ΔFR
(Fig. 4e). To gain insights into the structure of E123IR in its free
form, we examined the ΔδCα− ΔδCβ secondary chemical shifts,
which show this element is not a helix in isolation (Supplemen-
tary Fig. 3c)54. It seems likely that a combination of different
afﬁnities for different partners, and intrinsic conformational
plasticity could enable switching between E1-, E2-, and E3-bound
states.
Active site loop conformation in absence of Atg3E123IR. To
illuminate roles of Atg3E123IR-binding to the Atg3cat, we deter-
mined a crystal structure lacking these interactions for compar-
ison to the prior structure of full-length Atg3. The structure of a
version of Atg3 lacking the N-terminal 18 residues and the FR
region (Atg3ΔNFR) (Fig. 5a, Supplementary Fig. 4a, and Supple-
mentary Table 1), determined at 2.5 Å resolution, superimposes
well overall with that of full-length Atg3 (0.48 root-mean-square
deviation over C-alphas) (Fig. 5b). However, there are substantial
differences in the catalytic Cys loop and adjacent regions. As
described previously, in the structure of full-length Atg3, the
catalytic Cys234 is sequestered in a pocket formed by side chains
from the HR and two loops34. This orientation is catalytically
incompetent, with the Cys distal from the structurally important
Thr213 and from two other side chains (Tyr179 and His232) that
are important for the lipidation reaction (Fig. 5d, right)34,35,43. By
contrast, in the absence of the Atg3E123IR element, Atg3′s cata-
lytic center is structurally rearranged into an activated con-
formation through a domino-like effect that ultimately results in
remodeling a loop observed in full-length Atg3 into an additional
helical turn at the N-terminus of the HR (Fig. 5e); the remodeled
helix cannot restrain the side-chain from catalytic Cys234,
thereby allowing the alternative orientation where Cys234 is
surrounded by additional key catalytic residues (Fig. 5d, left).
Moreover, it appears that the extreme C-terminal region of Atg3
also rearranges between the E123IR-bound and other states: this
element undergoes a conformational change and additional C-
terminal residues are visible in the crystal structure of Atg3ΔNFR
relative to the prior structure of full-length Atg3. In the con-
formation in Atg3ΔNFR these residues would clash with the bound
E123IR (Supplementary Fig. 4b, c), although their nearby location
also suggests potential to positively interact with the E123IR in an
alternative, presently unknown conformation. Indeed, resonances
from these residues display large NMR chemical shift perturba-
tions when 15N-labeled Atg3cat is titrated with the unlabeled FR
(Fig. 4c).
Mutants displacing Atg3E123IR from Atg3cat activate ligation.
Interestingly, the activated orientation of the catalytic center was
observed previously in structures of full-length Atg3 when bound
to Atg7 (Supplementary Fig. 4b)40,43. Although interpreted as
stemming from indirect Atg7 interactions with the backside of
Atg3′s catalytic domain40,43, and/or from the high pH of the
crystallization conditions35, reinterpretation of the crystal struc-
tures with the knowledge that the Atg3E123IR element binds
Atg3′s catalytic domain in solution leads to a prediction: inter-
actions with Atg3E123IR would allosterically restrict Atg3′s cata-
lytic domain. However, displacement of the Atg3E123IR element,
either by deleting the FR domain (Fig. 5d), or upon binding to the
E1 Atg7 during formation of the Atg3~Atg8 intermediate (Sup-
plementary Fig. 4b), or upon binding to the Atg12–Atg5 portion
of E3 for the lipidation reaction35, would enable the active con-
formation. Nonetheless, relevance for the lipidation would
depend on the Atg3E123IR element binding in the context of an
Atg3~Atg8 complex. We tested this concept by NMR. First, a
stable proxy for Atg3ΔFR–Atg8 was made with a disulﬁde bond
between a Cys replacement for the C-terminal Atg8 residue and
the catalytic Cys in Atg3ΔFR (Atg3ΔFR–S–S–Atg8). Upon adding
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Fig. 3 E123IR interacts with autophagy E3. a [15N, 1H] TROSY spectra of 15N-labeled Atg3FR titrated with unlabeled Atg12–Atg5-Atg16. b Estimated binding
afﬁnities between E123IR residues and Atg12–Atg5, based on chemical shift perturbations (CSPs) observed upon titrating increasing concentrations of
Atg12–Atg5. c Chemical shift perturbations plotted as a function of Atg3FR residue numbers, with resonances showing intermediate exchange line
broadening indicated by stripes
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shift perturbations in [15N, 1H] TROSY spectra of 15N-labeled
Atg3FR (Fig. 6a) as for Atg3 alone (Fig. 4d).
If binding to the Atg3E123IR would be inhibitory, then
mutations in catalytic domain residues that mediate this
interaction and that are not needed for other Atg3 functions
should stimulate the lipidation reaction in the absence of E3.
Therefore, based on the crystallographic (Fig. 5e) and NMR data
(Fig. 4f), we generated several Ala substitutions designed to
disrupt the autoinhibitory interactions as follows: Asp133, which
is the only residue in the Atg3E123IR that does not bind Atg7 and
thus could form an Atg3~Atg8 intermediate, interacts with the
HR in full-length Atg3; Arg251 and Arg254 in the HR; Lys292,
Thr295, and Ser296 in the Atg3cat domain; and Gln302, His303,
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Fig. 4 E123IR binds the E1 Atg7 and E2 core domain Atg3cat. a Close-up showing interactions between Atg3E123IR and N-terminal domain (NTD) of Atg7
(PDB 3T7G). b Effects of Atg3E123IR-binding WT Atg7 NTD and non-binding mutant (P283D) on E3-stimulated intrinsic reactivity of Atg3~Atg8
intermediate, as monitored by pulse-chase discharge to NH2OH. c [15N, 1H] TROSY spectra of 15N-labeled Atg3cat alone (red) or in 1:44 mixture with
unlabeled Atg3FR (cyan), with chemical shift perturbations (CSPs) plotted per residue below. d [15N, 1H] TROSY spectra of 15N-labeled Atg3FR titrated with
unlabeled Atg3ΔFR, with representative (1:5 molar ratio Atg3FR vs. Atg3ΔFR) CSPs plotted per residue below. e Estimated binding afﬁnities between E123IR
residues and Atg3ΔFR, based on CSPs observed upon titrating increasing concentrations of Atg3ΔFR. f Residues corresponding to greatest CSPs are shown
as spheres on the structure of Atg3 (PDB 2DYT), except E308 and G309 that are not visible in the structure
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(Fig. 6b). These mutations mimicked effects of adding E3 to the
in vitro reactions lacking E3: relative to wild-type Atg3, they
activate the Atg3~Atg8 thioester-bonded intermediate (Fig. 6c
and Supplementary Fig. 5) and the lipidation reaction (Fig. 6d),
but are either not affected or defective for E3-dependent activity
(Fig. 2b and Supplementary Fig. 6c). The defect for one mutant in
E3-dependent activity can be explained due to its location in the
E123IR (D133A), but other mutants do not map to a region
presently known to be required for activity, although they may
reﬂect an activated conformation of the Atg3~Atg8 intermediate.
If this were the case, then the activation observed in the absence
of E3 may even be lower than theoretically possible.
Notably, increased Atg3~Atg8 discharge was not observed
upon adding liposomes together with the isolated Atg7NTD that
like E3 also binds the Atg3E123IR (Supplementary Fig. 5). Thus,
releasing the Atg3E123IR from the Atg3cat domain may not be
sufﬁcient for activating the lipidation activity of the Atg3~Atg8
intermediate. A potential difference between binding of the
Atg7NTD vs. Atg12–Atg5, or the effects of E3-mimicking
mutations, would be if the latter alter internal structural dynamics
of the Atg3~Atg8 intermediate so as to increase susceptibility to
nucleophilic attack.
To test the effects of the activating mutants in vivo, it is
necessary to examine Atg8 lipidation in the absence of the
proteins comprising the E3. We also wished to minimize
confounding effects of Atg8, Atg3, and the Atg12–Atg5-Atg16
complexes interacting with many proteins associated with







































Fig. 5 Conformational changes upon E123IR removal from Atg3. a Crystal structure of Atg3ΔNFR (PDB 6OJJ, from this study). b Superposition of Atg3ΔNFR
(PDB 6OJJ, light blue with catalytic Cys shown in green) with prior structure of Atg3FL (cyan, PDB 2DYT) with E123IR and catalytic Cys shown in red, and
differences highlighted in cartoons. c Fo–Fc map shown at 3σ after omitting the catalytic cysteine region (residues 231–237) of Atg3ΔNFR and performing
simulated annealing. d Close-ups of catalytic elements from Atg3ΔNFR and Atg3FL. e Close-up superposition of Atg3ΔNFR (light blue) and Atg3FL (cyan)
structures, showing interactions between Atg3′s catalytic domain and E123IR, and conformational rearrangements upon E123IR dislocation
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generated a minimal system for examining Atg8 lipidation
in vivo, with a plasmid expressing Atg7, HA-tagged versions of
Atg3, and the processed form of Atg8 in a yeast strain in which
these and 21 other autophagy (Atg) genes have been deleted
(MKO)55. Atg8 lipidation was markedly increased with the
majority of the mutants (Fig. 6e), which is remarkable given the
complexity of events required for the reaction and the large
number of other proteins that interact with Atg3 and Atg8
in vivo.
Extensive surfaces are required for Atg3~Atg8 activation. To
identify the portions of Atg8 and the Atg3 catalytic domain
contributing to the activated state, we performed mutagenesis.
E3-dependent discharge was monitored for 28 mutant versions of
Atg8 and 27 mutant versions of Atg3, each having one to four Ala
replacements for surface residues (Fig. 7a, b and Supplementary
Fig. 6a, b). The Atg8 mutations together probed the majority of its
surface, while Atg3 mutations encompass the catalytic domain
that is structurally homologous to canonical E2s and the short
C-terminal extension. A strikingly large fraction of the mutants
affected activation of Atg8 discharge. Notably, the majority of
the most defective mutants were also defective for Atg8
lipidation in vitro (Supplementary Fig. 7a, b) and in vivo (Sup-
plementary Fig. 7c). For Atg3, the defective mutants map to a
large continuous surface encompassing Atg3′s α1-, HR-, and
α5- (large central), α4- (adjacent to the catalytic center) helices,
and C-terminal extension (Fig. 8b). For Atg8, the mutations map
to two major surfaces. One corresponds to the canonical UBL
hydrophobic patch and C-terminus, and the other to the Atg8-
speciﬁc groove that binds AIM/LIR sequences in partner proteins
(Fig. 8c).
We hypothesized that some of the mutational defects could
reﬂect impaired interactions between Atg8 and Atg3 in the
covalent intermediate. Thus, we performed NMR considering
that prior studies of intrinsically active E2–UB intermediates
showed chemical shift perturbations indicating noncovalent
interactions between the covalently linked E2 and UB moieties.
Thus, we compared [15N, 1H] TROSY spectra for 15N-labled
Atg8 harboring a C-terminal Cys alone vs. in a disulﬁde-bonded
complex linked to the active site of unlabeled Atg3cat—i.e., in a
stable proxy for the Atg3cat–Atg8 intermediate (Fig. 7c).
The striking similarity between the locations of Atg8 NMR
resonances shifting upon covalent complex formation with Atg3
(Fig. 8c), and of mutants impairing E3-activated discharge from
Atg3 (Fig. 8b) raise the possibility of noncovalent interaction in a
so-called closed conformation. We used structural modeling to
consider potential parallels between the activated Atg3~Atg8
intermediate and a RING E3–E2–UB complex as representative.
First, the structure of Atg3 was superimposed with the
homologous region of the E2 UBE2D1 in the intermediate, and
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Fig. 6 Mutations in E123IR-binding residues activate Atg3~Atg8 in the absence of E3 in vitro and in vivo. a [15N, 1H] TROSY spectra of 15N-labeled Atg3FR
alone (red) or in 1:2 mixture with unlabeled, disulﬁde-bonded proxy for Atg3ΔFR–Atg8 (purple), with chemical shift perturbations (CSPs) per residue shown
below. b Locations of mutations a–e designed to impair interactions between Atg3′s catalytic domain and E123IR shown on crystal structure of Atg3 (PDB
2DYT). c Effects of indicated mutants in Atg3 catalytic domain-E123IR interface on intrinsic E3-independent activity of Atg3~Atg8 intermediate.
Quantiﬁcation is of WT or indicated mutant versions of Atg3~Atg8 remaining after 2.5 min as a function of NH2OH concentration in pulse-chase assays,
without E3, repeated 3 times repeats average (Error bar: STDEV, N= 3). Representative gel is shown in Supplemental Fig. 5; all data points are shown in
Source Data ﬁle. d Effects of indicated mutants in Atg3 catalytic domain-E123IR interface on E3-independent Atg8 lipidation in vitro, in reactions with Atg7,
Atg12–Atg5-Atg16, and liposomes generated from E. coli polar lipids as a source PE, and detected by migration of Atg8 in Coommassie-stained SDS-PAGE
gel. e Effects of indicated mutants in Atg3 catalytic domain-E123IR interface on E3-independent Atg8 lipidation in vivo, as detected by western blot for Atg8
after 4 h starvation of the YCY131 multi-Atg knockout strain of S. cerevisiae expressing Atg7, Atg10, Atg8ΔR (activated in absence of Atg4) and either WT
or mutant HA-tagged Atg3
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11435-y
8 NATURE COMMUNICATIONS |         (2019) 10:3600 | https://doi.org/10.1038/s41467-019-11435-y | www.nature.com/naturecommunications
(Fig. 8a). Next, the locations of mutations impairing activity, and
NMR chemical shift perturbations in the Atg3cat–Atg8 complex,
were analyzed, and found to be in striking concordance with the
corresponding interface residues in canonical E2–UB intermedi-
ates (Fig. 8b, c, d). The notable exceptions were the AIM/LIR
docking site in Atg8, Atg3 residues corresponding to E3-binding
regions of canonical E2s, and the extreme C-terminus of Atg3.
These regions are not shared between Atg3 and canonical E2s,
and the latter region is not fully visible in the crystal structures
presumably due to potential to adopt different conformations.
Nonetheless, the differences for the autophagy-speciﬁc regions
that are observed between the crystal structures (Supplementary
Fig. 4c), and in NMR chemical shift perturbations (Fig. 4c), for
the E123IR-bound and other forms of the Atg3 catalytic domain
are consistent with roles in allosteric regulation. Indeed, in using


























































































































































D54 Q59M1 E12 S18 R24 V31 A36 I41 K48
Fig. 7 Extensive surfaces of Atg8 and the Atg3 catalytic domain are required for activation of the Atg3~Atg8 intermediate. a E3-dependent activation of
Atg3~Atg8 intermediate testing roles of indicated surfaces through multiple-Ala scanning mutagenesis over Atg3′s catalytic domain. Quantiﬁcation is of
WT or indicated mutant versions of Atg3~Atg8 remaining after 2.5 min as a function of NH2OH concentration in pulse-chase assays, with Atg12–Atg5-
Atg16 as E3. b E3-dependent activation of Atg3~Atg8 intermediate testing roles of indicated surfaces through multiple-Ala scanning mutagenesis over
Atg8, performed as in (a). c Effects of covalent Atg3 complex formation with Atg8, as detected by comparing 15N, 1H] TROSY spectra of 15N-labeled Atg8
G116C (red) alone and disulﬁde-bonded complex with Atg3cat as a proxy for Atg3cat–Atg8 intermediate (cyan), with chemical shift perturbations per Atg8
residue shown below. Stripes indicate resonances with line-broadening due to intermediate exchange
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C-terminal residues of Atg3 approach the docked Atg8. On this
basis, it is tempting to speculate that this sequence, Met-Glu-Gly-
Trp, would adopt a reverse AIM/LIR motif anchoring Atg8–Atg3
in a closed conformation. Concordantly, mutation of these
residues has amongst the most deleterious effects (Fig. 7a and
Supplementary Figs. 6a, 7a), although future studies will be
required to visualize the structure of the E3-activated Atg3~Atg8
intermediate.
Discussion
Here, we demonstrated that Atg3 is restrained by an E123IR
element within its 70-residue FR bracing the active site; this brace
establishes regulation by interacting with E1 (Fig. 4a)42, E2
(Fig. 4c, d, f), and E3 (Fig. 3a, c); and that a key function of the
autophagy E3 Atg12–Atg5-Atg16 is to bind this brace to activate
the intrinsic reactivity of the thioester-bonded Atg3~Atg8 inter-
mediate (Fig. 4b). This unprecedented allosteric mechanism
underlying E2 activation—revealed by our NMR, crystal-
lographic, and mutational data, taken together with prior studies
—addresses the longstanding question of how Atg8 lipidation
is activated by an E3 that lacks sequence and mechanistic con-
servation with canonical conjugation enzymes. Notably,
E1-binding to the E123IR element is not sufﬁcient to activate the
Atg3~Atg8 intermediate (Supplementary Fig. 5), suggesting
additional roles for E3. Meanwhile, NMR data raise the possibility
that Atg3′s active site residues undergo conformational motions
on a different time-scale from the rest of catalytic domain, which
could impact enzymatic activity (Fig. 4c). Taken together, we
speculate that E3 binding to the Atg3~Atg8 intermediate broadly
inﬂuences dynamic or structural features of Atg3′s catalytic
domain that in turn bias the active site in favor of the reactive
conformation. Indeed, the need for E3-binding to activate the
Atg3~Atg8 intermediate in vitro is partially ameliorated by
mutations that map to the surfaces in and adjacent to the
Atg3cat–Atg3E123IR interface (Fig. 6c, d and Supplementary
Fig. 5). Physiological relevance is supported by such mutants also
activating E3-independent lipidation in vivo (Fig. 6e).
Although future studies will be required to visualize the
downstream steps in the reaction cascade, we propose that Atg8
lipidation involves Atg7, Atg3, and Atg12–Atg5-Atg16 toggling
their common interacting region in Atg3 as follows: (1) Prior to
encountering the Atg7–Atg8 intermediate, the Atg3E123IR binds
to the Atg3 catalytic domain to protect the active site Cys from






































































Fig. 8 Modeling of the active conformation of Atg3~Atg8 intermediate. a Generation of model for a potential closed E2~Ubl conformation for Atg3~Atg8,
with structures of Atg3ΔNFR (PDB 6OJJ, from this study) and Atg8 (PDB 2ZPN) superimposed on E2 and Ub, respectively, in a RING E3–E2–Ub complex
(PDB 4AP4). b Sites of Atg3 mutations impairing E3-dependent activation of Atg3~Atg8, mapped on model for closed conformation. Red—residues
corresponding to E2–Ub interface in closed conformation; wheat—residues corresponding to RING E3-binding site; bronze—residues in catalytic segment.
c Sites of Atg8 mutations impairing E3-dependent activation of Atg3~Atg8, mapped on model for closed conformation. Red—residues corresponding to
E2–Ub interface in closed conformation; orange—residues corresponding to AIM/LIR-binding site. d Atg8 residues showing chemical shift perturbation one
standard deviation above the mean upon covalent complex formation with Atg3, mapped on model for closed conformation. Red—residues corresponding
to E2–Ub interface in closed conformation; orange—residues corresponding to AIM/LIR-binding site
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N-terminal domain binds to Atg3′s E123IR element. This both
mediates E1–E2 interactions and conformationally activates Atg3′
s Cys to receive Atg8 from Atg7. (3) Following formation of the
Atg3~Atg8 intermediate, Atg3′s E123IR element could re-engage
the Atg3 catalytic domain to prevent Atg8 mis-ligation to a
nonspeciﬁc nucleophile. We speculate that this may also prevent
the extreme C-terminal residues of Atg3 from prematurely
adopting a conformation that contributes to the activate con-
formation of the Atg3~Atg8 intermediate. (4) Binding with
relatively higher afﬁnity, the Atg12–Atg5 portion of the autop-
hagy E3 subsequently dislodges Atg3′s E123IR, which enables
structural remodeling of the active site loop from a sequestered
position to an exposed conformation where the catalytic Cys is
juxtaposed with side chains that are crucial for Atg8 lipida-
tion (Fig. 9). Apparently, Atg12–Atg5 further activates the lipi-
dation reaction in a manner involving extensive surfaces
from both Atg3 and Atg8 in the Atg3~Atg8 intermediate. Due to
parallels to RING and SUMO E3 activation of canonical E2–UBL
intermediates45–47—both in stimulating intrinsic reactivity
and in the locations of the E2 and UBL residues involved—we
speculate that the Atg12–Atg5 autophagy E3 mediates activation
in part by promoting interactions between Atg3 and Atg8 in the
Atg3~Atg8 intermediate, although details of the interaction
remain to be discovered and may be distinct for the autophagy
enzymes.
Why might the autophagy UBL pathway involve such elaborate
allosteric control? It seems likely that key features of the ultimate
target, and intrinsic capabilities of the Atg3~Atg8 intermediate,
impose distinctive requirements for regulation. First, the substrate
PE is among the most abundant core glycerophospholipids.
Found in several organelles, PE’s widespread accessibility differs
from canonical UB and UBL substrates, which typically only are
licensed for modiﬁcation after a regulatory event such as a post-
translational modiﬁcation directs E3 binding. Second, through its
N-terminal membrane-curvature sensing helix, Atg3 itself can
bind the substrate PE37. The active site of Atg3~Atg8 may require
protection to prevent inopportune discharge to PE, and this is
best ensured by coming from the intermediate itself. Indeed,
when conformationally activated by E3-mimicking mutations,
Atg3~Atg8 cannot only catalyze the lipidation reaction and
in vivo, but also robustly discharges Atg8 to nonspeciﬁc nucleo-
philes even in the absence of E3. Thus, our data provide a
mechanism ensuring that Atg8 discharge is coupled to binding to
E3, which in turn establishes targeting speciﬁcity through several
features, including binding to cargo receptors56, and to mem-
branes27,31. The Atg16 moiety in the autophagy E3 could sub-
sequently engage the lipidated Atg8 to serve as a scaffold during
autophagosome biogenesis32.
Allosteric E2 activation is emerging as a common property of
E3 ligases45–47. It is now well-recognized that many E3 catalytic
domains stabilize a closed conformation that renders E2–UB and
E2–UBL intermediates susceptible to nucleophilic attack, while
other E3 domains mediate substrate targeting. Many E2s are
further activated allosterically, through their backside beta-sheets
binding to noncatalytic E3 domains. These effects have largely
been characterized for indirectly increasing binding to E3 RING
domains. However, some E3 or E3-associated domains also
trigger conformational changes at E2 active sites. For example,
the membrane E3-associated Cue1p binds to Ubc7p’s backside,
and indirectly modulates the active site, tens of angstroms away57.
Irrespective of whether E2 cysteines require protection from
errant nucleophilic attack, or coordination of catalytic activation
with other E3 functions, it seems likely that allosteric modulation
of E2 active sites serves as a failsafe ensuring UB and UBL dis-
charge at appropriate targets. The autophagy E2 Atg3 now sur-
faces as an ultimate case, with its brace self-imposed until directly
lifted by the E3 to drive autophagy.
Methods
Protein sequence alignment. ScAtg3 and HsATG3 protein sequence alignment
are done by CLUSTALW online.
Protein expression and puriﬁcation. Detailed methods for cloning, expressing
and purifying yeast proteins Atg8, Atg3 (and their mutants or truncated versions),
and Atg16 (residues 1–46) were described previously42,43,58. For Atg7 proteins,
full-length Atg7 or a fragment containing residues 1–289 (NTD) was inserted into
the pGEX-4T-1 vector following the Gibson Assembly protocol59, and transformed
into BL21 competent Escherichia coli; protein expression and puriﬁcation protocols
for Atg7 WT and mutants resemble those for Atg3 and Atg8. To obtain puriﬁed E3
complex, N-term 6X His-tagged Atg12 100–186 and untagged Atg5 1–284 were
inserted into the two multiple cloning sites (MSCs) of pRSF-Duet-1, respectively,
whereas Atg7 1–630 and Atg10 were inserted into the MSCs of pET-Duet-1. The
two plasmids are co-transformed into BL21 competent E. coli to produce His-
Atg12–Atg5. Bacteria culture were grown at 37 °C to reach O.D. 1.5, followed by
0.6 mM IPTG induction at 23 °C overnight. Cells are harvested in 1× phosphate-
buffered saline, 400 mM NaCl and lysed by sonication. Ni-NTA resin (Qiagen) was
incubated with lysate for 1 h then washed 3 times with the same buffer. His-
Atg12–Atg5 were eluted by buffer with 200 mM imidazole and immediately pur-
iﬁed by cation exchange chromatography on an S column (GE Healthcare). Pur-
iﬁed his-Atg12–Atg5 were combined with Atg16 1–46 in a 1:2 molar ratio and
further puriﬁed by size-exclusion chromatography on a Superdex-200 column
(GE Healthcare) to harvest peak factions containing the ﬁnal product of His-
Atg12–Atg5-Atg16.
Crystallization and data collection. Totally, 1 µL puriﬁed Atg3ΔNFR protein
sample was manually loaded onto a glass hanging-drop cover and overlaid with
1 µL of precipitant solutions. Crystal was harvested from 100mM HEPES pH 7.2,
150 mM L-malic acid, 9% PEG3350. Crystals were allowed to grow at 4 °C for
5–7 days to reach their maximum sizes. All crystals were harvested by loops with
25% glycerol in addition to growth solution, and stored in liquid nitrogen for


































Fig. 9 Schematic model for allosteric regulation of Atg3 activity through E123IR interactions across the lipidation cascade. The autophagy E2 Atg3 is
autoinhibited by AtgE123IR. When Atg3 encounters E1 Atg7, E123IR is relocated upon binding to Atg7NTD, thereby triggering rearrangement of the Atg3
catalytic core to activate Cys234 for attacking the Atg7–Atg8 intermediate. Atg8 is transferred from Atg7 to Atg8, producing the thioester-bonded
Atg3~Atg8 intermediate. Relieved from Atg7, Atg3E123IR protects the Atg3~Atg8 intermediate from wayward discharge to errant nucleophiles. The E3
(Atg12–Atg5-Atg16) binds E123IR and further activates the Atg3~Atg8 intermediate for nucleophilic attack. Numerous interactions with membranes place
this complex in proximity to PE for the lipidation reaction
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Data processing and structure reﬁnement. Data for Atg3ΔNFR was collected at
Advanced Photon Source (APS) Ser-CAT beamline 22-BM. The Dataset was cre-
ated from single crystals, and was processed and scaled in HKL2000. Phase was
solved by molecular replacement. Search model for Atg3ΔNFR was modiﬁed from
Atg3FL (PDB 2DYT) with Atg3E123IR manually removed. Model was built in
Coot60, and reﬁnements were primarily performed in Refmac61 and ﬁnalized in
Phenix62.
Simulated annealing omit map generation. In order to avoid the model bias, we
generated a simulated annealing omit map for the catalytic cysteine region. First,
residue 231–237 in the ﬁnal-reﬁned model was deleted; then, the model with
deletion was subjected to 3 rounds of reﬁnement in Phenix62 with simulated
annealing running from 5000 to 300 K in 50 steps. Finally, the Fo–Fc map was
shown at 3σ level along with the deleted residues in the model.
Atg3 C234 and Atg8 G116C disulﬁde cross-linking. All the cysteines except
C234 within Atg3 were mutated to alanines. 800 µM Atg8 K26P C22V G116C was
reduced by 20 mM DTT, desalted into buffer 1 (20 mM HEPES pH 7.5, 50 mM
NaCl), and immediately mixed with 1:1 v/v buffer 2 (20 mM HEPES pH 7.5,
50 mM NaCl, 2.5 mM 2,2′-dipyridyldisulﬁde (DPS). DPS stock was pre-dissolved
in a minimal amount of DMSO), incubated at room temperature (RT) for 20 min,
and desalted again into buffer 1. Meanwhile, 500 µM Atg3 was reduced by 20 mM
DTT and desalted into buffer 1, immediately mixed with DPS-Atg8 at a 1:2 molar
ratio, and incubated at RT for 1 h. Crosslinking product was puriﬁed by anion
exchange chromatography on Q column (GE Healthcare) and size-exclusion
chromatography on a Superdex-200 column (GE Healthcare).
NMR spectroscopy. All the experiments were conducted at 25 °C with protein
samples dissolved in 20 mM MES pH 6.5, 100 mM NaCl, and 10% v/v D2O on
either a Bruker Avance 600-MHz or 700-MHz or 800-MHz spectrometer equipped
with a 5-mm triple-resonance cryoprobe and a single-axis pulse ﬁeld gradient. For
resonance assignments of backbone atoms, 3D triple-resonance experiments
were measure either with 0.4 mM 13C, 15N, 2D-labeled or 13C, 15N-labeled Atg3cat,
0.75 mM 13C, 15N-labeled Atg3FR 86–159, and 0.4 mM 13C, 15N-labeled Atg8
K26P, C33V, G116C. The backbone assignment of Atg3cat was carried out using
3D HNCACB, HNcoCACB, HNCO, HNcaCO along with 15N-resolved [1H, 1H]
NOESY spectra. The backbone of Atg3FR 86–159 fragment peptide was assigned
using 3D HNCACB, CACBcoNH, HNCO, HNcaCO along with HNcocaNH
spectra. The backbone assignment of Atg8 K26P, C33V, G116C was carried out
using 3D HNCACB, HNcoCACB, HNCO, HNCA and HNcoCA along with 15N-
resolved [1H, 1H] NOESY spectra. Spectra were processed with Topspin 3.5 or
nmrPipe and analyzed using CARA. All chemical shift perturbation analyses were
done using [15N, 1H] TROSY spectra, and the perturbations were calculated using
the formula CSP (ppm)= ((δH)2+ 0.2*(δN)2)0.5. Titration experiments were done
using 0.1 mM 15N-labeled Atg3FR 86–159 (or its I132D, L135D, I136D mutant)
titrated with 0–150 µM Atg12–Atg5 (Fig. 3a), 0–500 (Fig. 4d) or 0–625 μM
Atg3ΔFR (Supplementary Fig. 3a), or 0 and 0.2 mM unlabeled Atg3ΔFR C234–Atg8
K26P, C33V, G116C disulﬁde complex (Fig. 6a); 0.1 mM 15N-labeled Atg3cat was
titrated with 0 or 4.4 mM unlabeled Atg3FR 123–147 (Fig. 4c). Also spectrum from
0.1 mM 15N-labeled Atg8 was compared with 0.1 mM disulﬁde complex of unla-
beled Atg3cat cross-linked via C234 to 15N-labeled Atg8 K26P, C33V, G116C
(Fig. 7c). The CSP value is used in the titration plots to get the Kd values using the
equation: y= (y0+ x)/(x+ Kd), where x is the concentration and Kd is the dis-
sociation constant and y0 is a constant.
Since most of the resonances in Atg3FR mutant [I132D, L135D, I136R] have the
same chemical shifts as that of Atg3FR, the assignment of Atg3FR was used to assign
the resonances of Atg3FR mutant (Supplementary Fig. 3a). The assignment of the
mutated residues and the neighboring ones that shifted the most ambiguously
shifted to positions where new peaks appeared.
Liposome preparation. 2.5 mg of E. coli polar lipid extract (Avanti) was dissolved
in chloroform, solvent evaporated using a nitrogen stream, and re-dissolved in
250 µL 20 mM HEPES pH 7.0, 150 mM NaCl buffer. Product was passed through
100 nm nuclepore membrane (Whatman) installed in a mini extruder (Avanti) 15
times to obtain 10 mg/mL homogenized liposomes in solution.
In vitro pulse-chase assay for Atg3~Atg8 discharge to NH2OH. Shortly before
the starting the experiment, Atg3 and mutants were reduced with 20 mM DTT and
desalted by Zeba columns (Thermo Fisher Scientiﬁc) into reaction buffer. In the
pulse step, 5 µM Atg7, 20 µM Atg3, 40 µM Atg8, 1 µM ATP, and 1 µM MgCl2 were
mixed in 25 µL 20 mM HEPES pH 7.0, 150 mM NaCl buffer. After 1 h, pulse
reactions were quenched by adding Apyrase. In chase step, 5 µL of each pulse
product was incubated with 5 µL chase solution containing 5 µM Atg12–Atg5-
Atg16 and a course of NH2OH at RT for 2.5 min, or with liposome at a ﬁnal
concentration of 2 mg/mL added in a timely manner. Samples were analyzed by
4–12% Bis–Tris Protein Gels (Thermo Fisher Scientiﬁc) and stained with Coo-
massie Brilliant Blue. All raw data are available in the source data ﬁle.
In vitro assay for Atg8 lipidation. Atg3 and mutants were reduced and desalted
as described in the pulse-chase assay. Reactions were performed at 30 °C in 25 µL
volumes of 20 mM HEPES pH 7.0, 150 mM buffer, with 1 µM Atg7, 2 µM Atg3,
5 µM Atg8, 5 µM Atg12–Atg5-Atg16, 1 mM ATP, 1 mM MgCl2 and 1 mg/mL
liposome, and were monitored in timely manner. Totally, 6 µL of each reaction was
mixed with 6 µL 2× protein loading buffer. Samples were analyzed using a by 15%
urea gel at 4 °C and stained with Coomassie Brilliant Blue. All raw data are
available in the source data ﬁle.
Yeast strains and vectors. Yeast strains used in this study are listed in the table
below. The XLY161 and the YCY13155 cells were transformed with pRS416 vectors
harboring HA-tagged Atg3 (WT or mutants); the YCY131 cells were co-
transformed with pRS414–Atg7–Atg10–Atg8ΔR. For nutrient-rich conditions,
yeast cells were grown in synthetic minimal (SMD; 0.67% yeast nitrogen base, 2%
glucose, and auxotrophic amino acids and vitamins as needed) medium. For
nitrogen starvation, cells were ﬁrst cultured in appropriate SMD medium to mid-
log phase; they were then shifted to the SD-N medium (0.17% yeast nitrogen base
without ammonium sulfate or amino acids, 2% glucose). The XLY161 cells were
cultured in SMD-Ura to mid-log phase before they were shifted to SD-N medium
for 2 h. The YCY131 cells were cultured in SMD-Ura-Trp to mid-log phase before
they were shifted to SD-N medium for 4 h. All raw data are available in the source
data ﬁle.
Western blot. One OD of each of the yeast cultures was harvested and lysed in
50 μl MURB (50 mM NaH2PO4, pH 7.0, 2.5 mM MES, pH 7.0, 1% SDS, 3 M
urea, 0.5% β-mercaptoethanol, 1 mM NaN3, 0.2 μg/μl bromophenol blue) by
vortexing them with glass beads at 4 °C for 5 min. The samples were then heated
at 70 °C for 10 min before they were loaded onto and run in SDS-PAGE gels,
followed by transferring onto polyvinylidene ﬂuoride membranes. The mem-
branes were blocked with 5% skim milk, probed with primary antibodies
(1:3000, Atg8; 1:10,000, Dpm1; 1:3000, HA; and 1:10,000, Pgk1), and then
probed with horseradish peroxidase (HRP)-coupled secondary antibodies
(1:10,000, anti-rabbit and anti-mouse antibodies). Atg8 antiserum was generated
by injecting puriﬁed yeast Atg8 peptides into rabbits; Dpm1 antibody is pur-
chased from Molecular Probes (catalog# A-6429); antibody to the HA epitope is
from Sigma (catalog# H3663); Pgk1 antibody is a generous gift from Dr. Jeremy
Thorner, University of California, Berkeley. Goat anti-rabbit HRP sencondary
antibody is from Fisher (catalog# ICN55676), and rabbit anti-mouse HRP
sencondary antibody is from Jackson ImmunoResearch (catalog# 315-035-003).
Chemiluminescence images were obtained by developing ﬁlms in a dark room.
The standard-sized protein bands from the protein ladder lanes on the blots
were correspondingly hand-drawn using a pen onto the developed ﬁlms. The
hand-drawn protein ladders were not shown in the ﬁgures, but they can be
found in the source data ﬁle.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The coordinates and structure factors for Atg3ΔNFR have been deposited to the RCSB
Protein Data Bank with ID 6OJJ. The resonance assignments for Atg3cat, Atg3FR
(residues 86–159), and Atg8 have been deposited to the Biological Magnetic Resonance
Data Bank with the IDs 27922, 27923, and 27924, respectively for immediate release
upon paper publication. The source data for Figs. 1b, 2b, 2c, 4b, 6d, 6e, and
Supplementary Figs. 1b, 1c, 2, 5, 6a, 6b, and 7a–c are provided as a Source Data ﬁle.
Other data are available from the authors upon request.
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